To study the effect of CARM1 on the proteomics of human liver cancer cells, the total protein was extracted and analyzed by 10% SDS-polyacrylamide gel electrophoresis, and then the proteolytic peptides were analyzed by label-free mass spectrometry in the rLV group and the rLV-CARM1 group. This evidence concerns the gene CARM1 and liver cancer.